Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living with Heart Disease
Ventripoint Diagnostics Announces Support for the Global Congenital Heart Disease Alliance
Ventripoint Diagnostics Ltd. (VPT:CA) Shareholder/Analyst Call Transcript
Ventripoint Provides Videoconference Link to Annual General Meeting and Corporate Update
Ventripoint Announces Closing of $308,030 Non-Brokered Units Private Placement
Ventripoint Issues Shares for Payment of Debenture Interest
The $59B Quiet Shift Reshaping How Patients Access Care
Ventripoint to Exhibit at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
Ventripoint's VMS+ (TM) 4.0 Submitted for Regulatory Approval in China by Lishman Global Inc.
Ventripoint Issue Shares for Payment of Debenture Interest
Ventripoint's VMS+(TM) 4.0 Recognized with Gold Edison Award, Validating Leadership and Future Potential
Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group
Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group
How Decentralized AI is Unlocking Value in Cardiac Diagnostics
Ventripoint Partners with First Light Health to Bring AI-Powered Cardiac Diagnostics to Indigenous and Remote Communities
Ventripoint Issues Shares for Payment of Debenture Interest and Reports on Debenture Conversions
Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes
Ventripoint Diagnostics Ltd. Signs Commercial Agreement with LG Consulting Solutions to Support VMS+ Deployment in Northern California
Ventripoint Diagnostics Ltd. (VPT:CA) Shareholder/Analyst Call Transcript
CEO.CA's Inside the Boardroom: Why Ventripoint is the Most Profitable "Bolt-On" Solution for Modern Hospitals
Ventripoint Provides Corporate Update and Announces Shareholder Video Conference Call
Ventripoint Issues Shares for Payment of Debenture Interest and Reports on Debenture Conversions
Ventripoint Issues Shares for Debt Settlement and Awards Option Grants
AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market
Ventripoint Announces Closing of Non-Brokered Units Private Placement
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic
Ventripoint Issues Shares for Payment of Debenture Interest
Ventripoint Doubles the Size of Private Placement Due to Strong Investor Demand
Ventripoint Announces Non-Brokered Units Private Placement
Ventripoint Diagnostics Announces Collaboration with Summit Sciences
Ventripoint to Issue Shares for Payment of Debenture Interest
Ventripoint Unveils a Global Model for A.I.-Enhanced Heart Care through Partnership with the Nisga'a Valley Health Authority
Ventripoint Diagnostics Announces Appointment of David Swetlow as Chief Financial Officer
CEO.CA's Inside the Boardroom: Ventripoint Diagnostics: We Made Ultrasound as Good as MRI - Now Here's How We Scale It
Ventripoint Announces Debt Settlement Agreements
Ventripoint Diagnostics Ltd. (VPT:CA) Shareholder/Analyst Call Transcript
Ventripoint Diagnostics and Providence Health Care Ventures Announce Collaboration to Validate AI-Enabled Cardiac Imaging at St. Paul's Hospital
Ventripoint Provides Corporate Update and Announces Shareholder Teleconference
Ventripoint Announces Closing of Second and Final Tranche of Non-Brokered Convertible Debenture Units Private Placement
Ventripoint Announces Extension and Up Size of Non-Brokered Convertible Debenture Unit Private Placement
Ventripoint Announces Successful Completion of Key Quality Audits
Ventripoint Announces Closing of First Tranche of Non-Brokered Convertible Debenture Unit Private Placement
Ventripoint Announces Non-Brokered Convertible Debenture Units Private Placement and Share Issuance
Ventripoint Diagnostics Appoints Thomas Brown as Director of Congenital Heart Defect Program
Ventripoint Diagnostics Launches Targeted Congenital Heart Defect Marketing Program, Setting Stage for Multi-Segment Growth
CEO.CA's Inside the Boardroom: Cardiac MRI Alternative Gets FDA Nod - Ventripoint CEO on U.S. and China Sales Plans
Lishman Global Places First Order for Ventripoint's VMS+ Technology
Ventripoint and Lishman Global Sign Non-binding Term Sheet Defining License for VMS+ Technology
Ventripoint to Issue Shares for Payment of Debenture Interest
Ventripoint Partners with Fournel Advisory